Childrens Cancer Research Fund is located in Minneapolis, MN. The organization was established in 1998. According to its NTEE Classification (T50) the organization is classified as: Philanthropy, Charity & Voluntarism Promotion, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. As of 12/2023, Childrens Cancer Research Fund employed 55 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Childrens Cancer Research Fund is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Childrens Cancer Research Fund generated $18.4m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 6.1% each year. All expenses for the organization totaled $18.3m during the year ending 12/2023. While expenses have increased by 6.3% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Childrens Cancer Research Fund has awarded 254 individual grants totaling $69,195,386. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
CHILDREN'S CANCER RESEARCH FUND IMPROVES THE HEALTH OF CHILDREN WITH CANCER AND THEIR FAMILIES.
Describe the Organization's Program Activity:
RESEARCH AND GRANTING PROGRAMS:IN 2023, CCRF AWARDED OVER $6 MILLION IN RESEARCH AND PROGRAM GRANTS DESIGNED TO FUND THE BEST, MOST INNOVATIVE RESEARCH TO ADVANCE TOWARD BREAKTHROUGH TREATMENTS FOR CHILDREN WITH CANCER, IN THESE AREAS OF FOCUS: - HARD TO TREAT CANCERS: WE PRIORITIZE RESEARCH FOR CANCERS WITH PERSISTENTLY LOW SURVIVAL RATES OR THOSE SHOWING LITTLE IMPROVEMENT OVER THE YEARS. THIS ENCOMPASSED HIGHLY AGGRESSIVE AND OFTEN FATAL CANCERS SUCH AS BRAIN TUMORS, SARCOMAS, AND CERTAIN TYPES OF LEUKEMIAS. IN 2023, WE ALLOCATED $1.3 MILLION TOWARDS A RESEARCH INITIATIVE AT CHILDREN'S HOSPITAL OF PHILADELPHIA, FOCUSING THEIR EFFORTS ON NEUROBLASTOMA. COLLABORATING WITH ORGANIZATIONS NATIONWIDE, WE CONTRIBUTED TO A $1.5 MILLION OSTEOSARCOMA SUPER GRANT AWARDED TO A RESEARCH AT NEW YORK MEDICAL COLLEGE. MOREOVER, WE PROVIDED $1.0 MILLION IN FUNDING FOR BRAIN TUMOR RESEARCH AT THE UNIVERSITY OF MINNESOTA. - SURVIVORSHIP: MANY SURVIVORS OF CHILDHOOD CANCERS GRAPPLE WITH ENDURING CONSEQUENCES OF CHEMOTHERAPY, RADIATION, OR SURGICAL INTERVENTIONS, INCLUDING HEARING IMPAIRMENT, CARDIAC ISSUES, AND INFERTILITY. FURTHER INVESTIGATION IS ESSENTIAL TO DEVELOP STRATEGIES FOR EFFECTIVELY MANAGING POST-CANCER CONDITIONS IN CHILDREN AND YOUNG-ADULTS, AIMING TO MITIGATE OR ERADICATE THESE LONG-TERM EFFECTS, PARTICULARLY CONCERNING NOVEL IMMUNE-BASED AND TARGETED THERAPIES DEVELOPED IN RECENT YEARS. NOTEWORTHY IN 2023, WE GRANTED $250,000 TO A RESEARCHER AT WASHINGTON UNIVERSITY IN ST. LOUIS, CONCENTRATING ON LONG-TERM COGNITIVE OUTCOMES IN SURVIVORS OF PEDIATRIC BRAIN TUMORS. - HEALTH DISPARITIES: DISPARITIES IN CANCER OUTCOMES AMONG CHILDREN ARE INFLUENCED BY FACTORS SUCH AS RACE, ETHNICITY, AND SOCIOECONOMIC BACKGROUND. OUR FUNDING SUPPORTS RESEARCH AIMED AT UNCOVERING THE ROOT CAUSES OF THESE DISPARITIES AND DEVISING INTERVENTIONS TO RECTIFY THEM. IN 2023, WE ALLOCATED $250,000 TO RESEARCH BEING DONE AT DANA-FARBER CANCER INSTITUTE, DEDICATED TO INVESTIGATING POVERTY-INDUCED DRUG RESISTANCE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL). - EMERGING SCIENTISTS: WE IDENTIFY AND SUPPORT EXCEPTIONALLY SKILLED RESEARCHERS AT THE OUTSET OF THEIR CAREERS, AIDING THEM IN ESTABLISHING THEIR LABORATORIES AND CONDUCTING PRELIMINARY INVESTIGATIONS. THIS SUPPORT LAYS THE FOUNDATION FOR THEM TO SECURE THE ESSENTIAL FEDERAL GRANTS NECESSARY TO ADVANCE NOVEL THERAPIES AND POTENTIAL CURES FOR PEDIATRIC CANCERS. NOTABLY, WE GRANTED $200,000 TO RESEARCHERS AT VIRGINIA POLYTECHNIC INSTITUTE & STATE UNIVERSITY AND ST. JUDE RESEARCH HOSPITAL FOR THEIR EFFORTS FOCUSED IN OSTEOSARCOMA RESEARCH AND THE DEVELOPMENT OF TARGETED THERAPIES. - SUSTAINING PROMISING RESEARCH INITIATIVES: RECOGNIZING THE POTENTIAL OF TWO PREVIOUSLY SUPPORTED RESEARCH ENDEAVORS THAT HAVE EXHIBITED ENCOURAGING RESULTS, WE EXTENDED ADDITIONAL FUNDING TO THE INVESTIGATORS, ENABLING THEM TO CONTINUE THEIR MOMENTUM. A TOTAL OF $375,000 WAS GRANTED TO RESEARCHERS AT DANA-FARBER CANCER INSTITUTE AND UNIVERSITY OF SOUTHERN CALIFORNIA SAN FRANCISCO, SUPPORTING THEIR ONGOING INVESTIGATIONS INTO SARCOMA CANCERS AND RELAPSED LIVER CANCER. THIS EXTENSION ENSURE THE CONTINUITY AND PROGRESSION OF THEIR VITAL WORK IN THESE CRITICAL AREAS OF STUDY.
EDUCATION AND AWARENESS PROGRAM:IN ADDITION TO FUNDING RESEARCH AND OFFERING SUPPORT PROGRAMS, WE GENERATE AWARENESS ABOUT THE NEED FOR CHILDHOOD CANCER RESEARCH AND PROVIDE EDUCATIONAL RESOURCES FOR RESEARCHERS. WE REACH MILLIONS OF PEOPLE THROUGH OUR WEBSITE, DIGITAL AND SOCIAL MEDIA PLATFORMS, AND IN-KIND TELEVISION AND PRINT ADVERTISING TO SHARE THE STORIES OF KIDS, FAMILIES, AND RESEARCHERS. WE'RE ALSO PROUD TO SUPPORT THE CANCER SURVIVORSHIP CONFERENCE, THE MARK E. NESBIT LECTURESHIP IN PEDIATRIC ONCOLOGY, AND THE NORMA K.C. RAMSAY, MD, DISTINGUISHED VISITING PROFESSOR LECTURESHIP SERIES. THESE BRING NATIONALLY RECOGNIZED CHILDHOOD CANCER EXPERTS TO MINNESOTA TO SPEAK ON CURRENT SURVIVORSHIP, CLINICAL AND RESEARCH ISSUES, AS WELL AS BUILD NEW RESEARCH COLLABORATIONS.
FAMILY SUPPORT PROGRAMS:OUR DEDICATED FAMILY PROGRAMS IMPROVE THE WELL-BEING OF KIDS AND FAMILIES AS THEY NAVIGATE THE DIFFICULT EXPERIENCES OF CANCER TREATMENT, SURVIVORSHIP, OR BEREAVEMENT. THESE OFFERINGS INCLUDE: - THE BIG DREAMS TOUR - A CREATIVE OUTLET THAT REDUCES ISOLATION BY LEVERAGING AR, VR, AND XR TECHNOLOGY TO PROVIDE PEDIATRIC CANCER PATIENTS AN OPPORTUNITY TO GAME TOGETHER MONTHLY AND CREATE THEIR OWN ANIMATED MUSIC VIDEO, VIDEO GAME, OR VFX VIDEO; INCLUDING COMMUNITY EVENTS WHERE THEIR CREATIONS ARE BROUGHT TO LIFE IN COLORADO, FLORIDA, MAINE, MINNESOTA, AND NEW JERSEY. - CAMP NORDEN - IN-PERSON AND VIRTUAL FIVE-DAY SUMMER CAMPS ARE DESIGNED ESPECIALLY TO MEET THE UNIQUE NEEDS OF CHILDREN WHO HAVE BEEN DIAGNOSED WITH CANCER AND SUPPORT FRIENDSHIP-BUILDING, SOLIDARITY WITH PEERS, INCREASED SELF-ESTEEM, AND A FEELING OF INDEPENDENCE. THESE CAMPS FOSTER COMMUNITY AND ELIMINATE FINANCIAL OR GEOGRAPHICAL BARRIERS TO ATTEND.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Jean Machart Coo, Interim CEO Through June | OfficerTrustee | 40 | $270,944 |
Elizabeth Allen CEO Beginning July | OfficerTrustee | 40 | $113,942 |
Kenna Dooley - Vice President Of Development & Donor Relations | 40 | $180,517 | |
Megan Martinez Director Of Marketing | 40 | $156,862 | |
Erin Cohen Director Of Events & Partnerships | 40 | $152,128 | |
Mary Maiden Mueller Technology, Data & Analytics Manager | 40 | $119,472 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
The Events Movement Usa Event Production | 12/30/23 | $1,812,500 |
Rr Donnelley Printing And Mailing | 12/30/23 | $1,359,967 |
Redpath Group Consulting Consulting | 12/30/23 | $242,203 |
Salesforce Software | 12/30/23 | $188,416 |
Thriveon Inc It Services | 12/30/23 | $166,521 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $434,340 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $17,520,165 |
Noncash contributions included in lines 1a–1f | $1,392,066 |
Total Revenue from Contributions, Gifts, Grants & Similar | $17,954,505 |
Total Program Service Revenue | $0 |
Investment income | $172,078 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $152,408 |
Net Income from Fundraising Events | $64,479 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $18,385,764 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $5,840,759 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $413,233 |
Compensation of current officers, directors, key employees. | $93,344 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $3,160,200 |
Pension plan accruals and contributions | $118,093 |
Other employee benefits | $258,593 |
Payroll taxes | $266,328 |
Fees for services: Management | $0 |
Fees for services: Legal | $18,244 |
Fees for services: Accounting | $30,000 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $14,969 |
Fees for services: Other | $1,788,587 |
Advertising and promotion | $2,725,284 |
Office expenses | $788,904 |
Information technology | $364,518 |
Royalties | $0 |
Occupancy | $203,867 |
Travel | $49,571 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $254,138 |
Insurance | $25,748 |
All other expenses | -$161,460 |
Total functional expenses | $18,303,331 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $5,020,292 |
Savings and temporary cash investments | $3,339,667 |
Pledges and grants receivable | $1,652,632 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $89,688 |
Net Land, buildings, and equipment | $504,204 |
Investments—publicly traded securities | $4,622,297 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $1,185,331 |
Total assets | $16,414,111 |
Accounts payable and accrued expenses | $468,526 |
Grants payable | $8,314,577 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $1,185,551 |
Total liabilities | $9,968,654 |
Net assets without donor restrictions | $4,182,014 |
Net assets with donor restrictions | $2,263,443 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $16,414,111 |
Over the last fiscal year, Childrens Cancer Research Fund has awarded $8,727,745 in support to 71 organizations.
Grant Recipient | Amount |
---|---|
CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE PURPOSE: CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE: 2021 CCRF HTT ALEX HUANG MD FINAL PAYMENT | $125,000 |
CHILDREN'S HOSPITAL OF LOS ANGELES PURPOSE: CHILDREN'S HOSPITAL OF LOS ANGELES: 2021 HTT PETER CHIARELLI FINAL PAYMENT | $125,000 |
CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE PURPOSE: CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE: 2021 CCRF SURVIVORSHIP DR LISA SCHWARTZ FINAL PAYMENT | $125,000 |
CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE PURPOSE: CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE: 2022 SURVIVORSHIP AWARD DR SOGOL MOSTOUFI-MOAB FIRST PAYMENT | $125,000 |
DANA-FARBER CANCER INSTITUTE INC PURPOSE: DANA-FARBER CANCER INSTITUTE, INC.: 2021 CCRF SURVIVORSHIP AWARD- DR KATIE GREENZANG FINAL PAYMENT | $125,000 |
DANA-FARBER CANCER INSTITUTE INC PURPOSE: DANA-FARBER CANCER INSTITUTE, INC.: 2022 DISPARITIES DR KIRA BONA 1ST PAYMENT | $125,000 |